推荐应用
LIR8, also known as CD85c and LILRB5, belongs to the Leukocyte immunoglobulin-like receptors (LILR) family of transmembrane glycoproteins involved in regulating immune responses. There are at least thirteen LILR family members and are divided into activating (LILRA) or inhibiting (LILRB) molecules. Mature human LIR8 consists of an extracellular domain (ECD) with four Ig-like domains, a transmembrane segment, and a cytoplasmic domain with two immunoreceptor tyrosine-based inhibitory motifs (ITIM). Alternative splicing of human LIR8 generates at least 2 isoforms, one lacking the second Ig-like domain. The LILR family appears to be primate-specific receptors in terms of sequence homology. LIR8 is expressed on NK cells and in the tryptic granules of mast cells and negatively regulates immune cell activation. It is present on the mast cell surface following cell activation and degranulation. Activated mast cells may also release soluble forms of LIR8.
高纯度、高活性、低内毒素、高批间一致性
产品数据

-25 ~ -15℃保存,收到货之后有效期1年。
复溶后, 无菌条件下,-85 ~ -65℃保存,3个月有效期。
【应用方向】BCMA/TNFRSF17:多发性骨髓瘤免疫治疗的核心靶点蛋白
137
2026-08-31
【应用方向】CD20:B细胞恶性肿瘤免疫治疗的核心靶点蛋白
145
2026-08-31
【应用方向】CD19:血液肿瘤免疫治疗的核心靶点蛋白
162
2026-08-31
【文献解读】Science 重磅成果:西湖大学团队攻克共价蛋白药物核心瓶颈,建立通用高通量速效蛋白筛选平台
310
2026-06-25
【技术讲解】信号通路系列 | Wnt/β-catenin信号通路:细胞的“信号转换器”与“命运规划师”
681
2026-04-29
【文献解读】EGFR信号通路的耐药新视角:当EGFR-TKI遇上免疫压力,肿瘤如何“金蝉脱壳”?
469
2026-04-29
【应用方向】免疫检查点核心家族:B7-CD28超家族蛋白
1083
2026-04-21
【应用方向】TIM-3:下一代肿瘤免疫检查点治疗的核心靶点
790
2026-04-21
【应用方向】SIRP家族分子详解与产品选择指南
667
2026-04-21
【应用方向】OX40-OX40L共刺激轴的T细胞存活调控
738
2026-04-21
【应用方向】LILRB家族:髓系细胞免疫检查点的研究前沿与产品解决方案
972
2026-04-21
【应用方向】LAG-3(CD223):T细胞耗竭调控网络的核心节点
895
2026-04-21
【应用方向】B7-H3(CD276):双重功能免疫检查点的分子特征与科研应用
1444
2026-04-20
【应用方向】HER2靶点蛋白:驱动肿瘤靶向治疗的核心力量
14643
2026-03-02
【技术讲解】细胞因子科学选型--常见问题解答
11251
2026-09-21





